Monoclonal antibody production process in 2026: uncover the key yield bottlenecks across media, single-use systems, clarification, and Protein A to improve recovery, control COGs, and scale with confidence.

ISPE's first white paper on extractables risk control for single-use bioreactor bags sets a new global benchmark—learn how it reshapes supplier qualification, testing protocols, and regulatory strategy.

US-China Pact slashes nucleic acid reagents export clearance time by 40%—unlock faster FDA pre-filing, CNAS certification & supply chain agility.

Japan PMDA fast-track for recombinant proteins as excipients cuts review time to 90 days—boost market entry, compliance & global supply chain agility.